Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:05 AM
Ignite Modification Date:
2025-12-25 @ 3:05 AM
NCT ID:
NCT07080333
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years old
* Male
* First RTUV for suspected CV in the presence of macroscopic haematuria or other clinical signs and/or urinary cytology and/or cystoscopy and/or imaging tests suggestive of CV
* Signed informed consent form
* Affiliation with a social security scheme
Exclusion Criteria:
* Antibiotic use within 3 months prior to inclusion
* Current urinary tract infection (urine culture recommended by the AFU prior to RTUV)
* History of surgical treatment of the urinary and genital tracts within the last 6 months prior to inclusion
* History of RTUV
* History of pelvic radiotherapy
* Interstitial cystitis
* Patients with an indwelling urinary catheter
* Vulnerable patients: minors, patients under guardianship or curatorship
* Patients with benign tumours after receipt of the pathological report (inverted papilloma, non-tumour inflammatory lesion)
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT07080333
Study Brief:
Protocol Section:
NCT07080333